SCI & TECH● LOWAug 19 · Aug 19, 2026, 10:49 AM
Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
CNBC
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH35m agoMoonshot AI resets Kimi K3.1 Pro quotas after user complaintsSeeking Alpha TechSCI & TECH53m agoBe nice, not nasty: Nobel laureate Geoffrey Hinton on why AI needs humans at its heartEuroNews [en]SCI & TECH1h agoBooks and AI: how the new human authorship certificates workClarínSCI & TECH1h ago'Pure garbage': Elon Musk’s AI-generated 'The Odyssey' clip ridiculed onlineEuroNews [en]